HSD17B13 drugs for MASH / NASH

2 tracked HSD17B13 drugs in the MASH / NASH race. The class explanation lives on the HSD17B13 page; the full indication pipeline across every mechanism is on the MASH / NASH page.

2 Phase 2

Head-to-head evidence: Gatuzosiran vs Rapirosiran (ALN-HSD)

The roster

← all HSD17B13 drugs